account_id none on file
legal_name Eton Pharmaceuticals, Inc.
ticker ETON
cik 1710340
domain etonpharma.com
linkedin_company_url https://www.linkedin.com/company/etonpharma/
entry_point_account_id none on file
name Eton Pharmaceuticals Inc.
exchange Nasdaq
sector Health Care
sector index/company/sector/health-care/
calls 1 filings 3 executives 5 family 0
why_nownone on file
calls
In fact, tomorrow, I will be traveling to San Antonio with our commercial team leader for the Chronic Liver Disease Foundation Liver Connect Conference to discuss Galvin with hepatologists and Wilson disease key opinion leaders.
Mar 18, 2025 / receipt, needs a key / Sean, CEO | earnings call 2025-03-18 | transcript d82d2e2c-61d5-42da-baf7-c71a6bc68e21 | chars 50225-50453 | segment 52
filings
General administrative expenses for the quarter were $11.6 million compared to $9.7 million in the prior year period, an increase of 20%. | G&A spend is rising 20%; approach Finance and Ops with effic
company_statement / Aug 13, 2026 / receipt, needs a key
The increase was primarily driven by additional headcount to support the growth of our business, with FDA fees accounting for $0.9 million of the year-over-year increase. | Target HR and Sales leaders
company_statement / Aug 13, 2026 / receipt, needs a key
We expect full-year R&D spending to be between $10 and $14 million, including the $3 million upfront licensing payment for ASN-001 which we expect to expense as R&D in the third quarter of 2026. | R&D
company_statement / Aug 13, 2026 / receipt, needs a key
executives
| Danka Radosavljevic | More | - | receipt |
| David Krempa | David is responsible for our business development, corporate strategy, and investor relations activities. | - | receipt |
| Ipek Erdogan | Chief Commercial Officer | - | receipt |
| James Gruber | Chief Financial Officer | receipt | |
| Shawn Fringelson | CEO | - | receipt |
familynone on file
upcoming
| 2026-11-05 | earnings call | scheduled | ir |
changes
| 2026-08-04 | Chief Operating Officer, appointed | sec_8k |
| 2023-03-01 | Chief Business Officer, appointed | sec_8k |
| 2022-04-11 | Chief Financial Officer, appointed | sec_8k |
| 2021-03-17 | director, departed | sec_8k |
mcp_package_hint
slug eton-pharmaceuticals-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$